US Patent

US11413296 — Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

Formulation · Assigned to Meritage Pharma Inc · Expires 2026-11-09 · 0y remaining

Vulnerability score 73/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods and pharmaceutical compositions for preventing or alleviating symptoms and inflammation in the gastrointestinal tract.

USPTO Abstract

Provided herein are methods for preventing or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract, for example, those involving the esophagus. Also provided herein are pharmaceutical compositions useful for the methods of the present invention.

Drugs covered by this patent

Patent Metadata

Patent number
US11413296
Jurisdiction
US
Classification
Formulation
Expires
2026-11-09
Drug substance claim
No
Drug product claim
Yes
Assignee
Meritage Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.